GlassScriptPhysician profile
Ketan Parekh
NPI 1972706463
$949.65
in general payments reported to CMS, 2019-2025
10 companies · $73.80 in 2025
The $73.80 reported for 2025 was less than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $62.23 · 2021: $78.95 · 2022: $49.27 · 2024: $67.04 · 2025: $73.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $571.83 | 2019-2021 | |
| Kls-Martin L.P. | $83.05 | 2022-2024 | |
| Dental Health Products, INC. | $73.80 | 2025 | |
| Dentsply Sirona INC | $53.84 | 2019 | |
| Keystone Dental INC. | $43.66 | 2019 | |
| Zimmer Biomet Holdings, INC. | $38.64 | 2020 | |
| Biohorizons Implant Systems INC. | $27.37 | 2021-2022 | |
| Implant Direct Sybron International LLC | $23.08 | 2019 | |
| Dash Medical Gloves LLC | $20.00 | 2022 | |
| Ace Surgical Supply Co., INC. | $14.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ketan Parekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.